- Home
- MOLN vs EGAN Comparison
MOLN vs EGAN Comparison
Compare MOLN & EGAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- EGAN
- Stock Information
- Founded
- MOLN 2004
- EGAN 1997
- Country
- MOLN Switzerland
- EGAN United States
- Employees
- MOLN N/A
- EGAN N/A
- Industry
- MOLN
- EGAN Computer Software: Prepackaged Software
- Sector
- MOLN
- EGAN Technology
- Exchange
- MOLN Nasdaq
- EGAN Nasdaq
- Market Cap
- MOLN 192.4M
- EGAN 186.5M
- IPO Year
- MOLN 2021
- EGAN 1999
- Fundamental
- Price
- MOLN $5.04
- EGAN $6.33
- Analyst Decision
- MOLN
- EGAN Buy
- Analyst Count
- MOLN 0
- EGAN 2
- Target Price
- MOLN N/A
- EGAN $9.50
- AVG Volume (30 Days)
- MOLN 5.7K
- EGAN 103.9K
- Earning Date
- MOLN 03-13-2025
- EGAN 02-14-2025
- Dividend Yield
- MOLN N/A
- EGAN N/A
- EPS Growth
- MOLN N/A
- EGAN 37.92
- EPS
- MOLN N/A
- EGAN 0.19
- Revenue
- MOLN $7,105,397.00
- EGAN $90,426,000.00
- Revenue This Year
- MOLN N/A
- EGAN $1.52
- Revenue Next Year
- MOLN $29.41
- EGAN $10.05
- P/E Ratio
- MOLN N/A
- EGAN $33.12
- Revenue Growth
- MOLN N/A
- EGAN N/A
- 52 Week Low
- MOLN $3.32
- EGAN $4.71
- 52 Week High
- MOLN $12.70
- EGAN $7.83
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- EGAN 50.24
- Support Level
- MOLN $5.22
- EGAN $5.81
- Resistance Level
- MOLN $5.35
- EGAN $6.71
- Average True Range (ATR)
- MOLN 0.12
- EGAN 0.26
- MACD
- MOLN -0.03
- EGAN -0.07
- Stochastic Oscillator
- MOLN 0.00
- EGAN 52.22
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About EGAN eGain Corporation
eGain Corp automates customer engagement with an innovative Software as a service (SaaS) platform, powered by deep digital, Artificial intelligence (AI), and knowledge capabilities. It operates in the United States, the United Kingdom, and India. The company derives maximum of its revenues from North America. It provides its products to industries such as financial services, telecommunications, retail, government, healthcare, and utilities.